Delta 9 to Supply Cannabis to Province of British Columbia
WINNIPEG, MB (October 3, 2019) – DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) is pleased to announce that the British Columbia Liquor Distribution Branch (the "BCLDB") has provided the Company with authorization to supply non-medical cannabis to the BCLDB for retail sale in the province of British Columbia.
“This marks the fourth major provincial supply contract for Delta 9 after Alberta, Saskatchewan, and Manitoba,” said John Arbuthnot, CEO of Delta 9. “As we ramp up our overall production capacity in 2019 and 2020, we will continue to seek additional distribution contracts for our cannabis products in Eastern markets. This agreement is a major step toward realizing our vision of being a national distributor of cannabis. We are pleased to offer BC retail stores and consumers the opportunity to access Delta 9’s premium branded cannabis products.”
The Company will begin supplying British Columbia with a variety of distinct, adult-use cannabis products under its premium Delta 9 brand name, in the fourth quarter of 2019. Delta 9 is in continued discussions with other provinces, territories and private retail outlets and plans to secure additional cannabis supply agreements over the rest of the year.
For more information contact:
Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
About Delta 9 Cannabis Inc.
Delta 9 Cannabis is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTC under the symbol VRNDF. For more information, please visit delta9.ca.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) increases in Delta 9's cannabis production capacity; (ii) shipments of cannabis to British Columbia; and (ii) Delta 9’s plans to secure additional cannabis supply agreements. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including all risk factors set forth in the annual information form of Delta 9 dated April 30, 2019 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.